Rimonci Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rimonci capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rimonci Capital Today - Breaking & Trending Today

Israeli company Addon Optics raised 12 million for multifocal technology

Israeli company Addon Optics raised 12 million for multifocal technology
jpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jpost.com Daily Mail and Mail on Sunday newspapers.

Samuel Vlodinger , Hagai Stadler , Eyal Hevroni , Addon Optics , Israel Shliser , Kli Capital , Rimonci Capital , Wilson Ave , Sapir Venture ,

Multifocal lens co Addon Optics raises $12m

The Israeli company's platform integrates an off-the-shelf single-focal lens with a proprietary flexible lens to create a high-quality progressive lens. ....

Israel General , Haim Engler , Amir Erlichman , Yoel Arieli , Jerusalem Lev Academic Center , Addon Optics , Kli Capital , Rimonci Capital , Wilson Ave , Sapir Venture , Addon Optic , Lev Academic , Israel Shliser ,

Addon Optics raises $12 million for multifocal lenses platform

The Israeli startup’s platform integrates an off-the-shelf single-focal lens with a proprietary flexible lens to create a high-quality progressive lens, using a machine the size of a 3D printer ....

Israel General , Haim Engler , Amir Erlichman , Yoel Arieli , Lehman Brothers , Lev Academic Center , Addon Optics , Kli Capital , Rimonci Capital , Wilson Ave , Sapir Venture , Optic Amir Erlichman , Tal Cohen , Code Red , Addon Optic , Snap Partners ,

EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt In China


EyeYon Medical Announces Innovative Medical Device Designation Granted For EndoArt In China
TEL-AVIV, Israel, April 7, 2021 /PRNewswire/ EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announces today that EndoArt was granted the Innovative Device Status by China s Center for Medical Device Evaluation, the arm of the National Medical Products Administration (NMPA). Following the announcement, the EndoArt became the only ophthalmic device in the world to receive both China s Innovative Device Status and the Breakthrough Device Designation from the U.S. Food and Drug Administration.
The EndoArt is the world s first synthetic implant that enables doctors to treat chronic corneal edema, the main reason for the world s most common organ transplant, with a minimally invasive surgery that erodes the use of human tissue.The EndoArt is designed to replace dysfunctional endothelium in patients awaiting huma ....

Richel Liu , Nahum Ferera , Kostenloser Wertpapierhandel , Yafit Lazar , China National Medical Products Administration , National Medical Products Administration , Drug Administration , China Center , Yon Medical , Innovative Device Status , Medical Device Evaluation , Breakthrough Device Designation , Innovative Device Designation , Rimonci Capital , Venture Capital , Eyeyon Medical , ரிச்செல் லியூ , யபித் லாசர் , சீனா மையம் , யோன் மருத்துவ , புதுமையானது சாதனம் நிலை , மருத்துவ சாதனம் மதிப்பீடு , திருப்புமுனை சாதனம் பதவி , புதுமையானது சாதனம் பதவி , துணிகர மூலதனம் ,